Terms: = Lung cancer AND FOXL2, BPES, 668, ENSG00000183770, P58012, PFRK, POF3, PINTO, BPES1 AND Treatment
53 results:
1. Evaluation of the preoperative neutrophil-to-lymphocyte ratio as a predictor of the micropapillary component of stage IA lung adenocarcinoma.
Chen C; Chen ZJ; Li WJ; Deng T; Le HB; Zhang YK; Zhang BJ
J Int Med Res; 2024 Apr; 52(4):3000605241245016. PubMed ID: 38661098
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive genomic profiling of pulmonary spindle cell carcinoma using tissue and plasma samples: insights from a real-world cohort analysis.
Sun Y; Qin S; Wang S; Pang J; Ou Q; Liang W; Zhong H
J Pathol Clin Res; 2024 May; 10(3):e12375. PubMed ID: 38661052
[TBL] [Abstract] [Full Text] [Related]
3. Segmentation of patients with small cell lung cancer into responders and non-responders using the optimal cross-validation technique.
Majd E; Xing L; Zhang X
BMC Med Res Methodol; 2024 Apr; 24(1):83. PubMed ID: 38589775
[TBL] [Abstract] [Full Text] [Related]
4. Long-Term Intracranial Outcomes With Combination Dual Immune-Checkpoint Blockade and Stereotactic Radiosurgery in Patients With Melanoma and Non-Small Cell lung cancer Brain Metastases.
Vaios EJ; Shenker RF; Hendrickson PG; Wan Z; Niedzwiecki D; Winter SF; Shih HA; Dietrich J; Wang C; Salama AKS; Clarke JM; Allen K; Sperduto P; Mullikin T; Kirkpatrick JP; Floyd SR; Reitman ZJ
Int J Radiat Oncol Biol Phys; 2024 Apr; 118(5):1507-1518. PubMed ID: 38097090
[TBL] [Abstract] [Full Text] [Related]
5. Eosinophil may be a predictor of immune-related adverse events induced by different immune checkpoint inhibitor types: A retrospective multidisciplinary study.
Tasaki Y; Sugiyama Y; Hamamoto S; Naiki T; Uemura T; Yokota K; Kawakita D; Nakamura M; Ogawa R; Shimura T; Mimura Y; Hotta Y; Odagiri K; Ito N; Iida M; Kimura Y; Komatsu H; Kataoka H; Takiguchi S; Morita A; Iwasaki S; Okuda K; Niimi A; Yasui T; Furukawa-Hibi Y
Cancer Med; 2023 Dec; 12(24):21666-21679. PubMed ID: 37986680
[TBL] [Abstract] [Full Text] [Related]
6. Prediction of subsolid pulmonary nodule growth rate using radiomics.
Ma ZJ; Ma ZX; Sun YL; Li C; Jin L; Gao P; Li C; Li M
BMC Med Imaging; 2023 Nov; 23(1):177. PubMed ID: 37936095
[TBL] [Abstract] [Full Text] [Related]
7. Real-world utilization of immune checkpoint inhibitors in extensive stage small-cell lung cancer in community settings.
Zu K; Arunachalam A; Hohlbauch A; Silver M; Robert N
Immunotherapy; 2023 Nov; 15(16):1375-1387. PubMed ID: 37694560
[TBL] [Abstract] [Full Text] [Related]
8. Optimizing Longitudinal Tobacco Cessation treatment in lung cancer Screening: A Sequential, Multiple Assignment, Randomized Trial.
Fu SS; Rothman AJ; Vock DM; Lindgren BR; Almirall D; Begnaud A; Melzer AC; Schertz KL; Branson M; Haynes D; Hammett P; Joseph AM
JAMA Netw Open; 2023 Aug; 6(8):e2329903. PubMed ID: 37615989
[TBL] [Abstract] [Full Text] [Related]
9. The International Association for the Study of lung cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
Wolf AS; Rosenthal A; Giroux DJ; Nowak AK; Bille A; de Perrot M; Kindler HL; Rice D; Opitz I; Rusch VW; Pass HI; ;
J Thorac Oncol; 2023 Dec; 18(12):1689-1702. PubMed ID: 37567386
[TBL] [Abstract] [Full Text] [Related]
10. Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors.
Liu Y; Mullangi S; Debono D; Chen X; Pham T; Fisch MJ; Gordon AS; Hershman DL
JCO Oncol Pract; 2023 Sep; 19(9):731-740. PubMed ID: 37384847
[TBL] [Abstract] [Full Text] [Related]
11. Real-world evaluation of atezolizumab and etoposide-carboplatin as a first-line treatment for extensive-stage small cell lung cancer.
Kim SH; Jo EJ; Mok J; Lee K; Kim KU; Park HK; Lee MK; Eom JS; Kim MH
Korean J Intern Med; 2023 Mar; 38(2):218-225. PubMed ID: 36800677
[TBL] [Abstract] [Full Text] [Related]
12. lung cancer recovery focus post pandemic: an income-deprived area paradigm.
Jaitly J; Mavilakandy A; Naeem M; Reddy RV; Goodman L; Johnson N; Frost M; Tsaknis G
Clin Med (Lond); 2023 Jan; 23(1):38-44. PubMed ID: 36697004
[TBL] [Abstract] [Full Text] [Related]
13. The effect of spiritual well-being on illness perception of lung cancer patıents.
Kahraman BN; Pehlivan S
Support Care Cancer; 2023 Jan; 31(2):107. PubMed ID: 36625978
[TBL] [Abstract] [Full Text] [Related]
14. Upfront Next Generation Sequencing in Non-Small Cell lung cancer.
Kuang S; Fung AS; Perdrizet KA; Chen K; Li JJN; Le LW; Cabanero M; Karsaneh OAA; Tsao MS; Morganstein J; Ranich L; Smith AC; Wei C; Cheung C; Shepherd FA; Liu G; Bradbury P; Pal P; Schwock J; Sacher AG; Law JH; Stockley TL; Leighl NB
Curr Oncol; 2022 Jun; 29(7):4428-4437. PubMed ID: 35877212
[TBL] [Abstract] [Full Text] [Related]
15. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.
Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q
Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614
[TBL] [Abstract] [Full Text] [Related]
16. Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016.
Nilssen Y; Brustugun OT; Eriksen MT; Guren MG; Haug ES; Naume B; Schlichting E; Møller B
BMC Cancer; 2022 Feb; 22(1):220. PubMed ID: 35227226
[TBL] [Abstract] [Full Text] [Related]
17. Duration of palliative care involvement and immunotherapy treatment near the end of life among patients with cancer who died in-hospital.
Auclair J; Sanchez S; Chrusciel J; Hannetel L; Frasca M; Economos G; Habert-Dantigny R; Bruera E; Burucoa B; Ecarnot F; Colombet I; Barbaret C
Support Care Cancer; 2022 Jun; 30(6):4997-5006. PubMed ID: 35192058
[TBL] [Abstract] [Full Text] [Related]
18. Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology Practices.
Anderson EC; DiPalazzo J; Edelman E; Helbig P; Reed K; Miesfeldt S; Thomas C; Lucas FL; Fenton ATHR; Antov A; Hall MJ; Roberts JS; Rueter J; Han PKJ
JCO Precis Oncol; 2021; 5():. PubMed ID: 34632254
[TBL] [Abstract] [Full Text] [Related]
19. IL-15-induced lymphocytes as adjuvant cellular immunotherapy for gastric cancer.
Hu Y; Liu D; Cui P; Zhang W; Chen H; Piao C; Lu Y; Liu X; Wang Y; Liu J; Lu X
Invest New Drugs; 2021 Dec; 39(6):1538-1548. PubMed ID: 34387808
[TBL] [Abstract] [Full Text] [Related]
20. PD-L1 Expression Status Predicting Survival in Pulmonary Pleomorphic Carcinoma.
Hisakane K; Seike M; Sugano T; Matsuda K; Kunugi S; Nakamichi S; Matsumoto M; Miyanaga A; Noro R; Minegishi Y; Kubota K; Gemma A
Anticancer Res; 2021 May; 41(5):2501-2509. PubMed ID: 33952478
[TBL] [Abstract] [Full Text] [Related]
[Next]
